Pre-treatment with the RSK1 inhibitor, BI-D1870, prevented the P4-induced phosphorylation of p27 at T198 and migration enhancement in both T47D and MCF-7 cells, suggesting that RSK1 activation plays an important role in the P4-induced migration enhancement in breast cancer cells. The gene discussed is RPS6KA1; the disease is breast cancer.